Vikas Lifecare Approves ₹200 Crore Share Sale for Growth

Introduction

Vikas Lifecare Limited's Board of Directors has approved significant strategic initiatives to bolster its financial standing and fuel expansion. In a meeting held on April 11, 2026, the board sanctioned a proposal to raise up to ₹200 crore through a preferential share issue. To facilitate this capital infusion, the company will also seek to increase its authorized share capital to ₹300 crore and amend its constitutional documents accordingly.

Details of the Fundraising Plan

The board has greenlit a plan to raise capital amounting to ₹200 crore via a preferential issuance of warrants and/or equity shares. This process will be executed in one or more tranches, adhering to the guidelines stipulated in Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. A dedicated Fund Raising Committee has been authorized by the board to oversee the implementation, which includes finalizing the allottees and determining the issue price based on the applicable SEBI pricing formula.

Strategic Capital Restructuring

To accommodate the new equity, the board approved a proposal to increase the company's authorized share capital to ₹300 crore. This enhanced capital will be composed of equity shares with a face value of Re. 1 each. This move necessitates corresponding amendments to the Capital Clause within the company's Memorandum of Association (MOA), setting the stage for future capital requirements.

Key Board Decisions at a Glance

Amendments to Corporate Governance

In line with the fundraising proposal, the board also approved significant alterations to the Articles of Association (AOA). A key change is the insertion of a "Further Issue of Capital" clause. These amendments are designed to align the company's governing documents with the proposed capital infusion and ensure full compliance with the Companies Act, 2013. The new clauses will establish clear procedures for offering shares to existing shareholders, employees under stock option schemes, and other individuals through special resolutions.

Purpose of the Capital Infusion

The primary objective of this fundraising initiative is to strengthen Vikas Lifecare's financial base to support its strategic growth plans. The capital is intended to fund both organic and inorganic growth opportunities, allowing the company to expand its business operations and explore new adjacencies. This proactive approach to securing long-term resources positions the company to capitalize on future market opportunities.

Investor Considerations and Market Context

Investors will be closely watching the finalization of the preferential issue, particularly the issue price and the profile of the allottees. It is important to note that the company has a history of net losses and declining profit margins, which may warrant caution. The price for the preferential allotment will be determined according to SEBI's pricing formula, ensuring regulatory compliance. The company's ability to effectively deploy the new capital towards its stated growth objectives will be a key factor in its future performance.

Financial Snapshot

Next Steps and Regulatory Path

The proposals are subject to approval from the company's members. Vikas Lifecare will seek this approval through a postal ballot, which will include an e-voting facility. The company has also appointed a scrutineer to oversee the voting process. Following shareholder approval, the company will proceed with the allocation of shares. All outcomes and further details will be disclosed to the National Stock Exchange (NSE) and BSE Limited, in compliance with SEBI's listing regulations.

Conclusion

Vikas Lifecare's decision to raise ₹200 crore and increase its authorized capital marks a pivotal step in its strategy to secure long-term growth. By strengthening its capital base, the company aims to enhance its operational capabilities and pursue expansion. The successful implementation of this plan hinges on shareholder approval and the effective deployment of funds to generate value and improve financial performance.